Profiling differentially expressed proteins in lung adenocarcinoma by label-free proteomics

邱满堂,祖桂利,姜冠潮
DOI: https://doi.org/10.3760/cma.j.cn421213-20200310-01086
2020-01-01
Abstract:Objective:This study was designed to profile protein expression in lung adenocarcinoma by label-free proteomics.Methods:Five treatment-na?ve lung adenocarcinoma patients were retrospectively selected, and total protein was extracted from the paired tumor tissues and adjacent normal tissues. The proteins were analyzed by high performance liquid chromatography-mass spectrometry. The raw data of mass spectrometry was blast to database and quantitatively analyzed by MaxQuant software. After blast to database, the MaxQuant generated data were analyzed by Perseus software. The differentially expressed proteins were further subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analyses. P value<0.05 was considered as statistically significant. Results:After blast to database, we achieved 11295 unique peptides belonging to 908 proteins. A total of 312 proteins were statistically differentially expressed in lung adenocarcinoma compared with adjacent tissues, and 110 proteins were upregulated, and 212 proteins were downregulated in lung adenocarcinoma. The ferritin was most upregulated in lung adenocarcinoma and collagen alpha-3 (VI) chain was most downregulated in lung adenocarcinoma. GO molecular function enrichment analyses showed that the differentially expressed proteins were enriched with function of poly (A) RNA binding and RNA binding.Conclusion:By the label-free proteomics approach, we identified 312 differentially expressed proteins in lung adenocarcinoma.
What problem does this paper attempt to address?